GLP-1 AXIS (SEMAGLUTIDE) Suppresses hunger centers, slows gastric emptying and enhances glucose-dependent insulin secretion affecting appetite and blood glucose
Every injection is performed under expert supervision for optimal safety and effectiveness
2021 [cited 2025 Mar 14]
Hashtags #MentalHealthAwareness #DepressionRecovery #BrainHealth #SSRIs #BDNF #Neuroplasticity #MentalWellness #HealingJourney #MindBodyConnection #Psychiatry #AnxietySupport #DepressionHelp #TherapyAndMedication #BrainFertilizer To view or add a comment, sign in Transcranial Magnetic Stimulation (TMS) offers a non-invasive, FDA-approved option for patients with treatment-resistant depression and OCD
White C, Ji S, Cai H, et al (2012) Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders
The key difference is in dosing, as tirzepatide escalation starts at 2.5mg rather than 0.25mg, which means much larger weekly doses and faster vial consumption